R61/R33: Mechanistic Research to Enable Precision Probiotic Therapies (Clinical Trial Optional)
This NIH NOFO funds milestone-driven, biphasic mechanistic research to identify person-specific factors (e.g., microbiome, immune status, sex, age, diet, genetics) that explain variable responses to probiotic interventions. The R61 phase supports observational or secondary-data studies to find host patterns linked to probiotic effects; the R33 phase tests causality in rigorous mechanistic stud…
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate the development of effective precision probiotic interventions using a milestone-driven, biphasic award mechanism. It aims to identify, understand, and develop strategies t…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic entities are NOT eligible to apply: Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statem…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers